Hergenrother Lab

Home Research
  • Complex Molecule Synthesis
  • Anticancer Compounds
  • Antibacterial Compounds
News Publications Group Members
  • Prof. Hergenrother
  • Post Docs
  • Graduate Students
  • Undergraduate Students
  • Visiting Scientists
  • Alumni
Group Business
  • Group Jobs
  • Group Meeting Schedule
  • Dissertations
Group Photos Resources & Links Misc.
  • Compound Collection
  • Funding
  • UIUC Affiliations

A Phase 1B/2 clinical trial of PAC-1 for patients with metastatic uveal melanoma is now enrolling

Posted on February 11, 2021July 1, 2021 by trubach@illinois.edu

To enroll in the trial, please visit the ClinicalTrials.gov website.

Posted in PAC-1

Post navigation

Previous: Congratulations to graduate student Matthew Boudreau for being awarded a prestigious fellowship from NCI!
Next: Read Young Innovator profile on Dr. Diana Ranoa, describing her pivotal role in developing the UIUC saliva test for COVID-19.

Hergenrother Lab

261 Roger Adams Lab

600 S. Mathews Avenue

Urbana, IL 61802

Email: hergenro@illinois.edu

Department of Chemistry
at the University of Illinois

Go to top